Dasatinib
Supplier:
Catalogue number:
SM45-500
Size:
500 mg
Product is available in:
Dasatinib is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit. Dasatinib treatment inhibits SRC signaling, decreases growth, and induces cell cycle arrest and apoptosis in a subset of thyroid cancer stem cells.
Product Type:
Peptides & proteins
CAS Number:
302962-49-8
Alternative Names:
BMS-354825, Sprycel, N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide